Get my own profile
Public access
View all8 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Michael N. HallBiozentrum, University of BaselVerified email at unibas.ch
- Dominic HoepfnerNovartis Institutes of Biomedical Research & Universität BaselVerified email at novartis.com
- Robbie LoewithUniversity of GenevaVerified email at unige.ch
- Ian StansfieldProfessor, University of AberdeenVerified email at abdn.ac.uk
- Mick TuiteEmeritus Professor of Molecular Biology, University of KentVerified email at kent.ac.uk
- Jeannette KunzAssociate Professor, Nazarbayev University School of MedicineVerified email at nu.edu.kz
- Florian NigschDirector Data Science, Novartis Institutes for BioMedical ResearchVerified email at flo.nigsch.com
- Guglielmo RomaGlaxoSmithKlineVerified email at gsk.com
- Sascha LoskoLabVantage - Biomax GmbHVerified email at labvantage-biomax.com
- Andreas W. SailerNovartisVerified email at novartis.com
- Yoshikazu OhyaProfessor of Genetics, University of TokyoVerified email at edu.k.u-tokyo.ac.jp
- Yann AbrahamJohnson & JohnsonVerified email at its.jnj.com
- Bernd BodenmillerDual Professor University of Zurich and ETH Zurich. Director, Department of Quantitative BiomedicineVerified email at uzh.ch
- Aebersold RETH ZurichVerified email at imsb.biol.ethz.ch
- Nahum SonenbergGilman Cheney Professor in BiochemistryVerified email at mcgill.ca
- John A. Porco Jr.Boston UniversityVerified email at bu.edu
- Gregory R. HoffmanHead of Cell Technologies, Sana BiotechnologyVerified email at sana.com
- Carsten RussVerified email at novartis.com
- Andrew SeeberTransition Bio IncVerified email at transitionbio.com
- Susan M. GasserFriedrich Miescher Institute for Biomedical ResearchVerified email at fmi.ch